Skip to main content

SurroMed Chooses Spotfire s Platform for Data Delivery

NEW YORK, Feb. 18 (GenomeWeb News) - SurroMed will use Spotfire's data analysis platform to share data with collaborators and customers interactively over the Internet, Spotfire said yesterday.


According to Somerville, Mass.-based Spotfire, its DecisionSite Posters platform will allow biomarker discovery company SurroMed, of Mountain View, Calif., to share live data and analytical results securely using a Web-based service.


The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.